Clinical Trials Logo

Muscular Dystrophies clinical trials

View clinical trials related to Muscular Dystrophies.

Filter by:

NCT ID: NCT06412328 Completed - Clinical trials for Duchenne Muscular Dystrophy

Psychoeducation Program for Parents of Children With DMD

Start date: June 21, 2023
Phase: N/A
Study type: Interventional

Having and caring for a child with disabilities brings emotional, social and economic difficulties for many families. Families may experience many physiological and psychological problems due to the stress and anxiety they experience. In addition, it is seen that families with children with disabilities give up their existing roles, reduce their participation in social activities, and reach stagnation in their social lives. Mothers are affected psychologically more than fathers and feel lonely. It is stated that mothers believe that they cannot afford everything in the face of the responsibilities they carry and accordingly, they experience emotional and psychological problems such as stress, anxiety, depression, absent-mindedness, forgetfulness and tantrums. Living with a child with a disability causes family members to experience different emotions as mentioned above; families may frequently experience fear, anxiety, guilt, anger and depression. It is reported that mothers of children with DMD experience depression, anxiety about the future and uncertainty more than mothers of healthy children. Families of children with DMD reported that they felt tired and fatigued during the process of caring for the child and had difficulties in participating in social activities and allocating time for themselves. Most of these families stated that they needed psychological and social support. Therefore, it is important to address the psychiatric aspects of families with children with DMD during the disease process. Parental health contributes positively to the health and adaptation of the family in general. Examining the psychiatric symptoms caused by the problems experienced by families related to DMD and how they cope with this stress will be useful in evaluating and addressing these families. In addition, the social support that families with children with disabilities receive from their immediate environment and institutions is also an important issue. It has been reported that social support from relatives, friends, neighbors, organizations and communities increases the psychological resilience levels of families, they feel that they are not alone in the face of problems, and their anxiety levels decrease. In the literature, it is generally mentioned that when the culture of pediatric care is supportive and family-oriented, the care of the patient will undergo a change when transitioning from pediatric care to the adult period. However, studies evaluating the problems experienced by families in the care of patients with DMD, psychiatric symptoms, ways of coping with stress and perceived social support are insufficient. It is important to evaluate the problems experienced by parents in the families of children with DMD in developing skills to cope with the disease process and disease-related problems, and then to provide training in these areas. Because if parents, who are in the role of caregivers, are equipped with knowledge and skills in this context, they will provide better care and be more useful to their children with DMD. In line with this information, the aim of this study was to evaluate the problems experienced by parents of children with DMD, psychiatric symptoms, coping skills with stress and the level of social support they perceive and to implement a psychosocial support-based psychoeducation program related to these areas.

NCT ID: NCT06411288 Not yet recruiting - Clinical trials for Myotonic Dystrophy 1

Phase 3 Global Study of Del-desiran for the Treatment of DM1

HARBOR
Start date: May 2024
Phase: Phase 3
Study type: Interventional

A Phase 3 Randomized, Double-Blind, Placebo-Controlled, Global Study to Evaluate the Efficacy and Safety of Intravenous Delpacibart Etedesiran (abbreviated del-desiran, formerly AOC 1001) for the Treatment of Myotonic Dystrophy Type 1

NCT ID: NCT06402942 Recruiting - Clinical trials for Duchenne Muscular Dystrophy

Gamified Occupational Therapy for Adolescents With Duchenne Muscular Dystrophy

DMD
Start date: June 1, 2024
Phase: N/A
Study type: Interventional

This research aims to improve the quality of life, occupational performance, occupational satisfaction and emotional health of young people with Duchenne muscular dystrophy compared to the classical occupational therapy program. The findings are planned to shed light on the development of new and effective strategies in the rehabilitation of adolescents with Duchenne muscular dystrophy.

NCT ID: NCT06399770 Not yet recruiting - Clinical trials for Limb-girdle Muscular Dystrophy

The Role of Muscle Ultrasound in Assessment of Sample of Patients With Limb-girdle Muscular Dystrophy

Start date: June 1, 2024
Phase:
Study type: Observational

1. to detect the characteristic patterns of muscle involvement in suspected cases of LGMD using muscle ultrasound 2. to use the muscle ultrasound findings clinically categorized the different types of LGMD 3. to correlate the muscle ultrasound findings with the findings of the other assissed scales

NCT ID: NCT06392724 Not yet recruiting - Clinical trials for Duchenne Muscular Dystrophy (DMD)

A Study to Evaluate the Safety and Tolerability of GEN6050X in Duchenne Muscular Dystrophy.

GEN6050XIIT
Start date: May 2024
Phase: Early Phase 1
Study type: Interventional

The study will evaluate the safety and tolerability of GEN6050X gene therapy in Duchenne muscular dystrophy (DMD) patients amenable to exon 50 skipping.

NCT ID: NCT06390566 Not yet recruiting - Clinical trials for Limb Girdle Muscular Dystrophy

Evolution of the Functional and Muscular State of Patients With Muscular Dystrophy 2A Belts

CALNATHIS
Start date: April 30, 2024
Phase:
Study type: Observational

Limb girdle muscular dystrophies were originally defined as a postnatal progressive muscle disease, which begins and primarily affects the pelvic and scapular muscles.

NCT ID: NCT06379906 Completed - Clinical trials for Duchenne Muscular Dystrophy

Upper Extremity Muscle Strength, Balance and Functional Skills in DMD

Start date: November 10, 2023
Phase:
Study type: Observational [Patient Registry]

This study aims to examine the relationship between upper extremity muscle strength, balance and functional skills of children with DMD.

NCT ID: NCT06378203 Recruiting - Clinical trials for Muscular Dystrophies

Rehabilitation in Muscular Dystrophies From the Hospital Facility to the Home: Pilot Project [RIMUDI]

RIMUDI
Start date: December 15, 2023
Phase: N/A
Study type: Interventional

Until twenty years ago physical exercise in muscular dystrophies was considered harmful to the muscle cells, inducing an acceleration of cell necrosis. In fact, it is now certain and validated that an active lifestyle and the practice of controlled and regular physical activity are to be considered therapeutic in neuromuscular pathologies with the aim of optimizing muscular and cardio-respiratory function and preventing atrophy In particular, it seems that the optimal care is extensive and can be carried out in a safe and controlled manner even at home. It is well documented that exercise has beneficial effects on muscle with increased strength and muscular endurance.

NCT ID: NCT06366815 Recruiting - Clinical trials for Duchenne Muscular Dystrophy

phenotypeS in Non Ambulant Duchenne Muscular Dystrophy

GUP21003
Start date: August 30, 2022
Phase:
Study type: Observational [Patient Registry]

The aims of the study are to prospectively collect information on several aspects of function in non-ambulant DMD patients by using a structured battery of tests including motor, respiratory and cardiac function

NCT ID: NCT06363526 Not yet recruiting - Clinical trials for Duchenne Muscular Dystrophy

Effectiveness of 5-week Digital Respiratory Practice in a Group of Children With Duchenne Muscular Dystrophy and Becker Muscular Dystrophy.

DMDrespy2024
Start date: May 5, 2024
Phase: N/A
Study type: Interventional

The purpose of this study is to analyze the effectiveness of a 5-weeks respiratory digital intervention program in patients with Duchenne muscular dystrophy and Becker muscular dystrophy.